Blood Market Analysis Perceive an Aggrandizing Growth by 2023 | Global Players Abbott, Becton Dickinson, CSL Behring, Immucor

According to Allied Market Research the global blood market was valued at $33,500 million in 2016, and is projected to reach $45,982 million by 2023, registering a CAGR of 4.6% from 2017 to 2023. The blood therapeutics segment contributed the highest share in 2016, owing to the increase in the demand for various plasma proteins for the recovery of patients.

The blood market products include whole blood collection, source plasma collection, blood therapeutics, blood typing products, blood screening, and blood processing equipment & associated products. Increase in geriatric population, rise in trauma cases, technological advancement in medical technology for donor screening, and advancement in blood transfusion instruments drive the market growth. However, rise in minimal invasive technology, which no longer require the blood transfusion hamper the market growth. Increase in peripheral nerve injuries and improvement in the healthcare facilities in Asia-Pacific provide growth opportunities for the market.

Download Sample @ https://www.alliedmarketresearch.com/request-sample/2297?utm_source=openpr_ss

Blood & blood component banks contributed the highest share in 2016, owing to the increase in the demand for using equipment for the blood processing and for segregation of the blood components. North America accounted for significant share in the global market in 2016, owing to an established healthcare industry and rise in number of patient population requiring blood & blood components.

Major Market Players:
• Abbott Laboratories
• Baxter International Inc.
• Becton Dickinson & Co.
• CSL Behring
• Immucor
• Novartis
• Novo Nordisk
• Ortho Clinical Diagnostics
• Roche Diagnostics
• Grifols International SA.

Key Findings of the Blood Market:
• In 2016, the blood therapeutics segment accounted for the highest share of the global blood industry market.
• The intravenous immunoglobulin segment contributed the highest revenue to the global market in 2016.
• The blood & blood component banks segment is projected to grow at the highest CAGR of 4.9% during the forecast period.
• North America is projected to grow at a CAGR of 4.4%.

Send Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/2297?utm_source=openpr_ss

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.